Madrigal (MDGL)


Madrigal


Company Description

Madrigal is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease and non-alcoholic steatohepatitis (NASH), diabetes, dyslipidemia and cardiovascular disease.


Company Info

COMPANY ADDRESS

200 Barr Harbor Drive
Suite 400
West Conshohocken, PA 19428
United States

COMPANY EMAIL

COMPANY WEBSITE

View Madrigal Stock Chart


Latest Company News